Anosmia and / or Ageusia and Early Corticosteroid Use
Anosmia and / or Ageusia in COVID-19: Timeline, Treatment With Early Corticosteroid and Recovery
Sponsor: ClinAmygate
This PHASE4 trial investigates Anosmia and Covid19 and is currently ongoing. ClinAmygate leads this study, which shows 14 recorded versions since 2021 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
14 versions recorded-
Nov 2025 — Present [monthly]
Unknown PHASE4
Status: Recruiting → Unknown
-
Sep 2024 — Nov 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
Oct 2023 — Jul 2024 [monthly]
Recruiting PHASE4
-
Dec 2022 — Oct 2023 [monthly]
Recruiting PHASE4
▶ Show 9 earlier versions
-
Sep 2022 — Dec 2022 [monthly]
Recruiting PHASE4
-
Jun 2022 — Sep 2022 [monthly]
Recruiting PHASE4
-
Apr 2022 — Jun 2022 [monthly]
Recruiting PHASE4
-
Sep 2021 — Apr 2022 [monthly]
Recruiting PHASE4
-
Apr 2021 — Sep 2021 [monthly]
Recruiting PHASE4
-
Mar 2021 — Apr 2021 [monthly]
Recruiting PHASE4
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE4
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Sep 2020 — Oct 2020 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ClinAmygate
For direct contact, visit the study record on ClinicalTrials.gov .